Investigational Drug Information for Proxalutamide
✉ Email this page to a colleague
What is the drug development status for Proxalutamide?
Proxalutamide is an investigational drug.
There have been 12 clinical trials for Proxalutamide.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 8th 2021.
The most common disease conditions in clinical trials are COVID-19, Coronavirus Infections, and Severe Acute Respiratory Syndrome. The leading clinical trial sponsors are Suzhou Kintor Pharmaceutical Inc,, Applied Biology, Inc., and Sun Yat-sen University.
There is one US patent protecting this investigational drug and four international patents.
Summary for Proxalutamide
US Patents | 1 |
International Patents | 4 |
US Patent Applications | 9 |
WIPO Patent Applications | 20 |
Japanese Patent Applications | 1 |
Clinical Trial Progress | Phase 3 (2021-02-08) |
Vendors | 28 |
Recent Clinical Trials for Proxalutamide
Title | Sponsor | Phase |
---|---|---|
A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects | IQVIA Biotech | Phase 3 |
A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects | Suzhou Kintor Pharmaceutical Inc, | Phase 3 |
A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients | Syneos Health | Phase 3 |
Clinical Trial Summary for Proxalutamide
Top disease conditions for Proxalutamide
Top clinical trial sponsors for Proxalutamide
US Patents for Proxalutamide
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Proxalutamide | ⤷ Try a Trial | Compositions and methods for treatment of prostate cancer | California Institute of Technology (Pasadena, CA) | ⤷ Try a Trial |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Proxalutamide
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Proxalutamide | Australia | AU2017321322 | 2036-08-29 | ⤷ Try a Trial |
Proxalutamide | Canada | CA3034257 | 2036-08-29 | ⤷ Try a Trial |
Proxalutamide | European Patent Office | EP3503898 | 2036-08-29 | ⤷ Try a Trial |
Proxalutamide | World Intellectual Property Organization (WIPO) | WO2018044817 | 2036-08-29 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |